Daily Stock Analysis, GNR, GENMARK DIAGNOSTICS INC, priceseries

GENMARK DIAGNOSTICS INC. Daily Stock Analysis
Stock Information
Open
43.35
Close
43.51
High
43.73
Low
43.31
Previous Close
43.30
Daily Price Gain
0.21
YTD High
47.11
YTD High Date
Apr 8, 2019
YTD Low
39.71
YTD Low Date
Jan 2, 2019
YTD Price Change
2.98
YTD Gain
7.35%
52 Week High
47.11
52 Week High Date
Apr 8, 2019
52 Week Low
38.69
52 Week Low Date
Dec 26, 2018
52 Week Price Change
-1.02
52 Week Gain
-2.29%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 21. 2017
45.90
Jan 30. 2018
49.24
25 Trading Days
7.29%
Link
LONG
Jan 4. 2019
41.49
Feb 7. 2019
43.70
23 Trading Days
5.33%
Link
LONG
Jun 6. 2019
43.04
Jul 5. 2019
45.32
20 Trading Days
5.29%
Link
LONG
Aug 29. 2019
41.48
Sep 24. 2019
43.65
17 Trading Days
5.23%
Link
Company Information
Stock Symbol
GNR
Exchange
NASDAQ
Company URL
http://www.genmarkdx.com
Company Phone
(760) 448-4300
CEO
Hany Massarany
Headquarters
California
Business Address
5964 LA PLACE COURT, CARLSBAD, CA 92008
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001487371
About

GenMark Diagnostics, Inc. is a molecular diagnostics company. The firm focuses on the development and commercializing of its its proprietary eSensor detection technology. It also manufactures, sells, and supports instruments and molecular tests. The company was founded by Jon Faiz Kayyem on February 12, 2010 and is headquartered in Carlsbad, CA.

Description

GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. The company provides XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents that enable reference laboratories and hospitals to support a range of molecular tests with a workstation and disposable test cartridges. It offers diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, warfarin sensitivity test, and thrombophilia risk test, as well as HCV genotyping test and associated custom manufactured reagents, and 2C19 genotyping test. The company also provides ePlex instrument and RP panel, which integrates automated nucleic acid extraction and amplification with its eSensor detection technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results without any additional steps. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.